Pharmaceutical Industry news

• Ultra-Endurance Running Accelerates Red Blood Cell Aging

  23-02-2026 18:16 via drugs.com
  MONDAY, Feb. 23, 2026-- Ultra-endurance running accelerates red blood cell (RBC) aging through inflammatory and oxidative pathways, according to a study published online Feb. 18 in Blood Red Cells & Iron.Travis Nemkov, Ph.D., from the...
  
  Read more

• ERA: Finerenone Leads to Slower Decrease in eGFR in Adults With CKD

  09-06-2026 17:44 via drugs.com
  TUESDAY, June 9, 2026-- Finerenone leads to a slower decrease in estimated glomerular filtration rate (eGFR) than placebo among adults with chronic kidney disease (CKD) without diabetes, according to a study published online June 4 in the New...
  
  Read more

• ERA: Semaglutide Improves Health-Related QoL in Adults With T2D, CKD

  09-06-2026 17:41 via drugs.com
  TUESDAY, June 9, 2026-- For adults with type 2 diabetes and chronic kidney disease, two years of semaglutide treatment improves health-related quality of life (QoL) versus placebo, according to a study presented at the annual congress of the...
  
  Read more

• SLEEP: Staying Up Late Tied to Worse Mental Health

  09-06-2026 17:39 via drugs.com
  TUESDAY, June 9, 2026-- Those who prefer to go to sleep later report poorer mental health, which is partially explained by greater reported loneliness, according to a study presented at SLEEP 2026, the annual meeting of the Associated Professional...
  
  Read more

• Advertisement

• SLEEP: Sleep Problems Linked to Later Psychological Well-Being

  09-06-2026 17:36 via drugs.com
  TUESDAY, June 9, 2026-- Sleep problems in middle-aged and older adults are associated with psychological well-being (PWB) nine years later, with the association stronger in women, according to a study presented at SLEEP 2026, the annual meeting of...
  
  Read more

• AI Risk Stratification Can ID High-Risk Women From Screening Mammograms

  09-06-2026 17:18 via drugs.com
  TUESDAY, June 9, 2026-- Artificial intelligence (AI) risk stratification generated from screening mammograms can identify women with a high risk for breast cancer, allowing expedited care, according to a study published online May 18 in npj...
  
  Read more

• Primary Infertility Linked to Earlier Menopause

  09-06-2026 17:16 via drugs.com
  TUESDAY, June 9, 2026-- Women with primary infertility have an increased risk for early menopause, according to a study published online June 2 in Menopause.Lillian J. Dyre, M.D., from the Mayo Clinic College of Medicine and Science in Rochester...
  
  Read more

• Bariatric Surgery Tied to Improvement in Performing Household Tasks

  09-06-2026 17:12 via drugs.com
  TUESDAY, June 9, 2026-- Bariatric surgery is associated with improved home management within the first year of surgery and is sustained for the long term, according to a study published online April 18 in BMC Medicine.Petra Brembeck, Ph.D., from...
  
  Read more

• Advertisement

• Fatherhood Tied to Greater Longevity in Black Men

  09-06-2026 17:08 via drugs.com
  TUESDAY, June 9, 2026-- Fatherhood in Black men appears to protect against all-cause mortality by middle age compared with nonfathers; however, Black men who became fathers younger than 29 years of age tended to have a higher risk for early death...
  
  Read more

• Study Looks at Barriers to Initiation of Rotavirus Vaccine

  08-06-2026 23:16 via drugs.com
  MONDAY, June 8, 2026-- Risk factors for not initiating rotavirus vaccine (RVV) -- for which the first dose is recommended by a maximum age of 14 weeks, 6 days -- include extremely preterm birth and having no health insurance, according to a study...
  
  Read more

• FDA Approves Xocova for COVID-19 Postexposure Prophylaxis

  08-06-2026 23:14 via drugs.com
  MONDAY, June 8, 2026-- The U.S. Food and Drug Administration has approved Xocova (ensitrelvir), an oral antiviral, for postexposure prophylaxis (PEP) of COVID‑19 in adults and adolescents aged 12 years and older.Xocova is approved as a five-day...
  
  Read more

• ADA: GLP-1 Receptor Agonist Use Beneficial in Adults With Obesity, Autoimmune Disease

  08-06-2026 18:01 via drugs.com
  MONDAY, June 8, 2026-- Glucagon-like peptide 1 receptor agonist (GLP-1 RA) use is associated with reduced risks for thromboembolic events, emergency department use, and mortality among adults with obesity and autoimmune diseases (AIDs), according...
  
  Read more

• ERA: Dihydropyridine Calcium-Channel-Blockers Tied to Higher Risk for Kidney Disease Progression in T2D

  08-06-2026 17:58 via drugs.com
  MONDAY, June 8, 2026-- For adults with type 2 diabetes receiving guideline-directed renin-angiotensin inhibitors (RASi) and sodium-glucose cotransporter-2 inhibitors (SGLT2i), dihydropyridine calcium-channel-blocker (DCCB) use is associated with...
  
  Read more

• EULAR: Obexelimab Can Lower Risk for Disease Flare in Active IgG4-Related Disease

  08-06-2026 17:55 via drugs.com
  MONDAY, June 8, 2026-- For patients with active immunoglobulin (Ig)G4-related disease, obexelimab, a bifunctional monoclonal antibody that inhibits B-cell activity, yields a significantly lower risk for disease flare, according to a study...
  
  Read more

• Complications Similar for Decompression With or Without Duraplasty for Chiari I and Syringomyelia

  08-06-2026 17:51 via drugs.com
  MONDAY, June 8, 2026-- For children with Chiari type I malformation and syringomyelia, surgical complications do not differ for those undergoing neurosurgical posterior fossa decompression (PFD) with duraplasty (PFD-D) versus PFD alone, according...
  
  Read more

• Oral Drug Combo Effective for Older Patients With Acute Myeloid Leukemia

  08-06-2026 17:48 via drugs.com
  MONDAY, June 8, 2026-- An oral drug combination is effective for older patients with acute myeloid leukemia (AML) who are ineligible for intensive chemotherapy, according to a study published in the June 4 issue of the New England Journal of...
  
  Read more

• Prayer at Primary Care Appointments Tied to Reductions in Pain, Anxiety

  05-06-2026 23:58 via drugs.com
  FRIDAY, June 5, 2026-- A five-minute session of proximal intercessory prayer (PIP) significantly reduces pain and anxiety in primary care patients, according to a study published in the May/June issue of the Annals of Family Medicine.Katherine...
  
  Read more

• ~16 Percent of COVID Cases Develop Postacute Sequelae of SARS-CoV-2

  05-06-2026 23:55 via drugs.com
  FRIDAY, June 5, 2026-- About 16 percent of COVID-19 cases develop postacute sequelae of severe acute respiratory syndrome coronavirus-2 infection (PASC), according to a study published online May 27 in JAMA Network Open.Jiazi Tian, from...
  
  Read more

• ASCO: Tile-Based Radiation Beneficial for Newly Resectable Brain Mets

  05-06-2026 16:44 via drugs.com
  FRIDAY, June 5, 2026-- For patients with newly diagnosed resectable brain metastases (BM), cesium-131 tile-based radiation therapy (TBRT), which delivers focal radiation immediately upon resection, yields significantly better outcomes than...
  
  Read more

• ASCO: Apalutamide + ADT Beneficial in High-Risk Localized Prostate Cancer

  05-06-2026 16:28 via drugs.com
  FRIDAY, June 5, 2026-- Perioperative treatment with apalutamide and androgen deprivation therapy (ADT) is beneficial for patients with high-risk localized or locally advanced prostate cancer, according to a study published online June 2 in the New...
  
  Read more

• Wearable Ultrasound Patch Provides Continuous Fetal Monitoring

  05-06-2026 16:26 via drugs.com
  FRIDAY, June 5, 2026-- A wearable ultrasound patch can provide continuous, real-time information about blood flow in the fetus and umbilical cord, according to a study published online May 26 in Nature Biotechnology.Geonho Park, Ph.D., from the...
  
  Read more

• Cardiometabolic Genetics Linked to Cognitive-Related Outcomes

  05-06-2026 16:23 via drugs.com
  FRIDAY, June 5, 2026-- A higher polygenic risk score (PRS) for pulse pressure is associated with an increased risk for dementia as a contributing cause of death (DCCD), according to a study published online June 3 in Neurology.Daeeun Kim, Ph.D...
  
  Read more

• Dose Reduction of Biologics Effective, Safe for Psoriasis

  05-06-2026 16:18 via drugs.com
  FRIDAY, June 5, 2026-- For patients with psoriasis with stable low disease activity, dose reduction (DR) through stepwise interval prolongation of interleukin (IL)-17 and 23 inhibitors (i) is effective and safe, according to a study published...
  
  Read more

• High Prevalence of Clinical Obesity Seen Even With Normal BMI

  04-06-2026 22:46 via drugs.com
  THURSDAY, June 4, 2026-- The prevalence of clinical obesity is high among those with normal body mass index (BMI) values, according to a research letter published online June 2 in the Annals of Internal Medicine.Hirsh Elhence, M.D., from the...
  
  Read more

• FDA Approves First Treatment for Chronic Hepatitis Delta Virus Infection

  04-06-2026 22:43 via drugs.com
  THURSDAY, June 4, 2026-- The U.S. Food and Drug Administration has approved Hepcludex (bulevirtide-gmod) injection to treat chronic hepatitis delta virus (HDV) infection in adults without cirrhosis or compensated cirrhosis.Hepcludex received...
  
  Read more

• ASCO: Lower Incidence of Breast Cancer Seen With GLP-1 Receptor Agonist Exposure

  04-06-2026 17:55 via drugs.com
  THURSDAY, June 4, 2026-- Glucagon-like peptide-1 receptor agonist (GLP-1 RA) exposure is associated with a lower incidence of breast cancer, according to a study published online June 2 in JCO Oncology Practice to coincide with the annual meeting...
  
  Read more

• ASCO: First-Line Sunvozertinib Beats Chemo for Advanced NSCLC

  04-06-2026 17:53 via drugs.com
  THURSDAY, June 4, 2026-- For patients with advanced non-small cell lung cancer (NSCLC) with epidermal growth factor receptor (EGFR) exon 20 insertion mutations, sunvozertinib is superior to chemotherapy for first-line treatment, according to a...
  
  Read more

• Patients From Most Rural Counties Have Worse Epilepsy Outcomes

  04-06-2026 17:50 via drugs.com
  THURSDAY, June 4, 2026-- Rurality is associated with worse epilepsy outcomes, although the associations are attenuated among privately insured patients, according to a study published online June 3 in Neurology.Edward R. Bader, M.B., Ch.B., from...
  
  Read more

• 2024 Saw Parkinson Disease Death Rate of 72 Per 100,000 Adults Aged 65 and Older

  04-06-2026 17:47 via drugs.com
  THURSDAY, June 4, 2026-- The age-adjusted Parkinson disease death rate among adults aged 65 years and older declined from 2021 to 2024, according to a June 4 data brief published by the National Center for Health Statistics.Ellen A. Kramarow...
  
  Read more

• Resistance Training Tied to Lower Risk for Death Across Causes

  04-06-2026 17:40 via drugs.com
  THURSDAY, June 4, 2026-- Ninety to 120 weekly minutes of strength training may lower the risk for death, with amplified effects when combined with aerobic activity, according to a study published online June 2 in the British Journal of Sports...
  
  Read more

Follow @PharmaIndustry_ on Twitter!